PHARMACEUTICAL PREPARATIONS CONTAINING MELATONIN AGENTS

Brand Owner (click to sort) Address Description
MELALERT Lewy, Alfred J. 14047 SE Fairoaks Way Milwaukie OR 97267 Pharmaceutical preparations containing melatonin agents for use in the treatment of circadian rhythm conditions;MEL ALERT;
MELALERT Lewy, Alfred J. 14047 SE Fairoaks Way Milwaukie OR 97267 Pharmaceutical preparations containing melatonin agents for use in the treatment of circadian rhythm conditions;
MELALERT-AM Lewy, Alfred J. 14047 SE Fairoaks Way Milwaukie OR 97267 Pharmaceutical preparations containing melatonin agents for use in the treatment of circadian rhythm conditions;MEL ALERT AM;
MELALERT-AM Lewy, Alfred J. 14047 SE Fairoaks Way Milwaukie OR 97267 Pharmaceutical preparations containing melatonin agents for use in the treatment of circadian rhythm conditions;
MELALERT-PM Lewy, Alfred J. 14047 SE Fairoaks Way Milwaukie OR 97267 Pharmaceutical preparations containing melatonin agents for use in treating circadian rhythm conditions;MEL ALERT PM;
MILKATONIN Lewy, Alfred J. 14047 SE Fairoaks Way Milwaukie OR 97267 Pharmaceutical preparations containing melatonin agents for use in the treatment of circadian rhythm conditions;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention provides medicinal or pharmaceutical compositions and preparations for administration, which are useful as cytoprotective agents and a remedy for neurotrauma, comprising ginseng, its extract, ginseng components, metabolites thereof or salts thereof (for example, red ginseng powder or components thereof). More particularly, the present invention provides medicinal or pharmaceutical compositions for inhibiting apoptosis or apoptosis-like cell death, medicinal or pharmaceutical compositions for promoting the expression of a cell death-suppressing gene product Bcl-xL, or preparations for oral or intravenous administration, comprising ginseng, its extracts, ginseng components, metabolites thereof or salts thereof preferably at low concentrations. These medicinal or pharmaceutical compositions and/or preparations for administration are characterized by containing, as the active ingredient(s), ginseng, its extracts, ginseng components, metabolites thereof or salts thereof at low concentrations. These drugs are useful for therapy, prevention or treatment of brain and nervous diseases, heart diseases, etc.